BioNTech (NasdaqGS:BNTX) named Dr. Guido Oelkers as incoming CEO, marking a major leadership transition at the company. The ...

As of October 11 at 2:23:00 AM UTC. Market Open. Fully-diluted value (FDV) is an estimate of a cryptocurrency’s Market Cap if the maximum supply were in circulation. The total value of a ...

Ex-BioNTech chief strategy officer Ryan Richardson is chief executive of the new outfit, which launches with $25 million in seed financing led by Redmile, Vsquared Ventures and Kindred Capital.

BioNTech earnings 2026 showed a stunning €700 million revenue guidance cut, slashing its full-year outlook to €1.6–1.9 ...

Guido Oelkers will guide BioNTech’s ongoing transition into an oncology-focused biotech, while co-founder and longtime leader ...

Guido Oelkers, Ph.D., appointed to BioNTech Management Board as Chief Executive Officer, taking office by February 1, 2027, at the latestAdvanced ...

A powerful tornado toppled power lines and trees around a driver in the Appleton, Wisconsin. The EF2 tornado caused widespread damage in the area.

BERLIN, Aug 4 (Reuters) - German vaccine maker BioNTech significantly lowered its full year sales outlook range on Tuesday due to softer-than-expected COVID-19 vaccine demand, as second quarter ...

Guido Oelkers is a seasoned CEO and strategic leader with over 30 years of experience in the biotechnology and pharmaceutical industries. He has a strong track record in transforming and scaling ...

Key 2026 catalysts include the trastuzumab pamirtecan BLA filing, pivotal Phase 3 oncology readouts, and a binary EPO patent ...

Check out the latest Biontech Se (BNTX) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Cathie Wood's biotech ETF has largely moved on from the vaccine maker.